Regarding estrogen signaling, the expression ratio between ERα and ERβ has a great effect on tumorigenesis in breast and ovarian cancers; ERβ was shown to have inhibiting effects on ERα and thus on cell proliferation. Here, ESR2 is linked to ovarian carcinoma.